Menu
Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

Leica Biosystems News & Events

Leica Biosystems introduces the Novocastra HD menu for dermatopathology, the third portfolio of antibodies for IHC in the new Novocastra HD range.

Published:
6th March 2013 Place: Newcastle-upon-Tyne, UK.   Leica Biosystems introduces the Novocastra HD menu for dermatopathology, the third portfolio of antibodies for IHC in the new Novocastra HD range. Each antibody has been independently assessed*...

Leica Biosystems introduces new Novocastra HD antibody menu for Head and Neck Pathology

Published:
Place: Newcastle upon Tyne   Leica Biosystems introduces new Novocastra HD antibody menu for Head and Neck Pathology The Novocastra™ HD menu for head and neck pathology comprises six antibodies#, each selected following extensive customer...

Announce Partnership to Develop Companion Diagnostic for HER2 Screening in Women with Breast Cancer

Published:
Galena Biopharma and Leica Biosystems Announce Partnership to Develop Companion Diagnostic for HER2 Screening in Women with Breast Cancer Leica Biosystems will develop a fully automated HER2 diagnostic  to support identification of appropriate HER2...

Leica Biosystems at NSH 2012, Vancouver

Published:
Earlier this week, we participated in the 38th Annual National Society of Histotechnology (NSH) Convention under the new Leica Biosystems brand. Our presence included providing demonstration equipment for workshops, our experts hosting education...

Increase Diagnostic Confidence and Laboratory Productivity with new Novocastra HD Antibodies for IHC

Published:
Leica Microsystems announces the introduction of the Novocastra™ HD antibody range, 80 clinically important immunohistochemistry antibody clones, spanning 10 anatomical pathologies.

Leica Biosystems receives FDA Approval for the Fully Automated Bond Oracle HER2 IHC System on the BOND-MAX

Published:
Newcastle Upon Tyne, England. Leica Biosystems, a division of Leica Microsystems, announced that it has received Pre-Market Approval from the U.S. Food and Drug Administration for the Bond Oracle HER2 IHC System (Product Code TA9145) with the...

Leica Microsystems and Epitomics Enter Agreement for Supply of Proprietary Rabbit Monoclonal Antibodies

Published:
Strengthening the Portfolio of Bond IHC Antibodies

Leica PELORIS e-Learning Announcement

Published:
Welcome to the online Leica PELORIS e-Learning!